Kiora Pharmaceuticals
KPRX
KPRX
14 hedge funds and large institutions have $284K invested in Kiora Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$89.1K | |
| 2 | +$58.7K | |
| 3 | +$50.9K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$43.6K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$41.5K |
Top Sellers
| 1 | -$286K | |
| 2 | -$113K | |
| 3 | -$40.1K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$17.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$17K |